BOCCARELLI, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 4.205
AS - Asia 1.865
EU - Europa 1.229
SA - Sud America 572
AF - Africa 119
OC - Oceania 4
AN - Antartide 1
Totale 7.995
Nazione #
US - Stati Uniti d'America 4.147
SG - Singapore 752
CN - Cina 577
BR - Brasile 481
SE - Svezia 289
HK - Hong Kong 225
RU - Federazione Russa 214
IT - Italia 194
DE - Germania 131
VN - Vietnam 119
UA - Ucraina 116
FI - Finlandia 99
CI - Costa d'Avorio 88
GB - Regno Unito 68
IN - India 40
AR - Argentina 38
ID - Indonesia 32
BD - Bangladesh 26
CA - Canada 25
FR - Francia 23
MX - Messico 22
JP - Giappone 19
BE - Belgio 16
EC - Ecuador 15
ZA - Sudafrica 15
IE - Irlanda 14
ES - Italia 12
NL - Olanda 12
IQ - Iraq 11
TR - Turchia 11
JO - Giordania 10
CO - Colombia 9
PL - Polonia 9
VE - Venezuela 8
CL - Cile 7
PY - Paraguay 7
AT - Austria 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
TN - Tunisia 6
IR - Iran 5
PE - Perù 5
UZ - Uzbekistan 5
AU - Australia 4
KR - Corea 4
LT - Lituania 4
GE - Georgia 3
KE - Kenya 3
RO - Romania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
MA - Marocco 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 7.995
Città #
Ashburn 402
Fairfield 400
Woodbridge 374
Chandler 370
Singapore 346
Jacksonville 262
Nyköping 242
Hong Kong 223
Houston 210
Seattle 191
Cambridge 171
Ann Arbor 164
Wilmington 157
Beijing 147
Bari 121
Nanjing 101
New York 91
Abidjan 88
Lawrence 88
Roxbury 88
Des Moines 60
Boardman 56
Los Angeles 54
Ho Chi Minh City 51
Dallas 49
Princeton 38
São Paulo 37
Helsinki 36
Brooklyn 35
Inglewood 31
Buffalo 28
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 25
Hanoi 22
San Diego 22
Santa Clara 22
Council Bluffs 21
Munich 21
Jiaxing 19
Tokyo 19
Jakarta 17
Pune 17
Belo Horizonte 15
Brussels 15
San Francisco 15
Tianjin 15
Brasília 13
Dublin 13
Columbus 12
Guangzhou 12
Moscow 12
Rio de Janeiro 12
The Dalles 12
Shanghai 11
Amman 10
Milan 10
Boston 9
Curitiba 9
Montreal 9
Porto Alegre 9
Amsterdam 8
Changsha 8
Johannesburg 8
Baghdad 7
Chennai 7
Kunming 7
Ningbo 7
Paris 7
Phoenix 7
Poplar 7
Salvador 7
Stockholm 7
Turku 7
Warsaw 7
Washington 7
Chicago 6
Denver 6
Dhaka 6
Goiânia 6
Hefei 6
London 6
North Bergen 6
Nuremberg 6
Quito 6
Ribeirão Preto 6
Wuxi 6
Ardabil 5
Brno 5
Charlotte 5
Jinan 5
Manchester 5
Mexico City 5
Tashkent 5
Toronto 5
Buenos Aires 4
Campinas 4
Campo Grande 4
Caxias do Sul 4
Totale 5.435
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 209
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 190
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 162
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 159
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 158
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 158
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 150
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 149
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 144
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 141
Endothelial cells in the bone marrow of patients with multiple myeloma 118
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 113
Platinum(II) based anticancer agents with a trans geometry 110
Antitumour platinum iminoether complexes 108
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 105
null 104
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 103
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 102
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 102
Antitumour ruthenium(II)-dimethylsulfoxide complexes 102
Antitumour platinum-iminoether complexes 101
Antitumour platinum iminoether complexes 100
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 100
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 100
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 99
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 97
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 94
null 91
Antitumor activity of trans platinum complexes 91
null 88
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 86
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 85
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 84
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 84
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 83
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 82
Bone Marrow Fibroblasts and Multiple Myeloma Progression 81
A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics 80
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 80
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 80
Inhibition of matrix metallo proteinases activity by platinum complexes 79
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 78
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 78
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity 77
Complessi antitumorali di platino a geometria trans 74
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 73
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 73
A trans-platinum complex showing higher antitumor activity than the cis congeners 71
A second life for MAO inhibitors? From CNS diseases to anticancer therapy 70
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 70
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 70
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 70
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 69
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 69
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 69
null 68
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 67
null 67
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 67
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 66
null 66
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 65
null 65
null 65
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 64
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 64
Screening tests for selecting anticancer metal compounds 62
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 62
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 61
A new generation of platinum anticancer complexes with trans geometry 61
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 60
DNA interaction properties of platinum –iminoether complexes 60
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 58
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 56
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 55
null 55
null 55
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 54
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 53
Complessi antitumorali di platino a geometria trans 53
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 53
null 53
Platinum(II) complexes with acyclovir: synthesis and biological activity 52
null 52
null 51
Interazione DNA-isomeri del [PtCl2(DACH)] 50
Complessi antimetastatici di rutenio 50
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 50
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 49
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 48
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 47
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 46
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 45
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 45
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 44
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 44
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 42
New platinum antitumor complexes with chiral diamines 41
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 41
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma 38
Totale 8.033
Categoria #
all - tutte 34.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021499 0 0 0 0 0 67 47 51 118 109 74 33
2021/2022555 15 90 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024430 30 50 19 18 60 135 4 33 11 10 2 58
2024/20251.540 89 26 129 52 59 113 232 103 52 65 243 377
2025/20261.811 440 148 295 439 435 54 0 0 0 0 0 0
Totale 8.397